155 related articles for article (PubMed ID: 22699860)
1. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
Busch M; Schwenzky A; Franke S; Stein G; Wolf G
Blood Purif; 2012; 34(1):3-9. PubMed ID: 22699860
[TBL] [Abstract][Full Text] [Related]
2. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
[TBL] [Abstract][Full Text] [Related]
3. The advanced glycation endproduct, pentosidine, in the carpal ligament in patients with carpal tunnel syndrome undergoing hemodialysis: comparison with idiopathic carpal tunnel syndrome.
Takahashi M; Hoshino H; Kushida K; Murata H; Baba S; Inoue T
Nephron; 1998 Dec; 80(4):444-9. PubMed ID: 9832644
[TBL] [Abstract][Full Text] [Related]
4. The relationship between pentosidine and hemodialysis-related connective tissue disorders.
Sakata S; Takahashi M; Kushida K; Oikawa M; Hoshino H; Denda M; Inoue T
Nephron; 1998; 78(3):260-5. PubMed ID: 9546683
[TBL] [Abstract][Full Text] [Related]
5. Carpal tunnel surgery as proxy for dialysis-related amyloidosis: results from the Japanese society for dialysis therapy.
Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
Am J Nephrol; 2014; 39(5):449-58. PubMed ID: 24819459
[TBL] [Abstract][Full Text] [Related]
6. Carpal tunnel syndrome and plasma beta2-microglobulin concentration in hemodialysis patients.
Shin J; Nishioka M; Shinko S; Shibuya K; Sugiki M; Kasumoto H; Fudo A; Bito Y; Fujita Y; Komaba K
Ther Apher Dial; 2008 Feb; 12(1):62-6. PubMed ID: 18257814
[TBL] [Abstract][Full Text] [Related]
7. Dialysis-related carpal tunnel syndrome in the past 40 years.
Hatano M; Kitajima I; Yamamoto S; Nakamura M; Isawa K; Suwabe T; Hoshino J; Sawa N; Ubara Y
Clin Exp Nephrol; 2022 Jan; 26(1):68-74. PubMed ID: 34415463
[TBL] [Abstract][Full Text] [Related]
8. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
10. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
Schiffl H
Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
[TBL] [Abstract][Full Text] [Related]
11. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
[TBL] [Abstract][Full Text] [Related]
12. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
13. [Beta 2-microglobulin and dialysis-related amyloidosis].
Gejyo F
Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
[TBL] [Abstract][Full Text] [Related]
14. Carpal tunnel syndrome in patients on intermittent hemodialysis.
Schiffl H
Blood Purif; 2012; 34(3-4):332; author reply 333. PubMed ID: 23306634
[No Abstract] [Full Text] [Related]
15. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.
Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763
[TBL] [Abstract][Full Text] [Related]
16. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
Haufe CC; Eismann U; Deppisch RM; Stein G
Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of dialysis-related amyloidosis: focusing on carpal tunnel syndrome].
Nishi S
Brain Nerve; 2014 Jul; 66(7):783-93. PubMed ID: 24998823
[TBL] [Abstract][Full Text] [Related]
18. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.
Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G
Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and carpal tunnel syndrome in hemodialysis patients: a single center cross-sectional study.
Yu L; Shen S; Zu Y; Huang J; Li H; Wang S
Ren Fail; 2020 Nov; 42(1):1076-1082. PubMed ID: 33070671
[TBL] [Abstract][Full Text] [Related]
20. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis.
Küchle C; Fricke H; Held E; Schiffl H
Am J Nephrol; 1996; 16(6):484-8. PubMed ID: 8955759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
